AAUM (Average Assets Under Management) of ₹1,494.01 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 60.3% | 58.3% | ▼ -2.0% |
| Healthcare Services | 31.9% | 33.2% | ▲ +1.4% |
| Fertilizers & Agrochemicals | 4.9% | 5.6% | ▲ +0.7% |
| Personal Products | 1.2% | 1.1% | ● -0.1% |
| Healthcare Equipment & Supplies | 0.0% | 0.9% | ▲ +0.9% |
| Insurance | 0.0% | 0.5% | ▲ +0.5% |
| Chemicals & Petrochemicals | 1.0% | 0.0% | ▼ -1.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 58.3% | 60.6% | ▲ +2.4% |
| Healthcare Services | 33.2% | 27.8% | ▼ -5.4% |
| Fertilizers & Agrochemicals | 5.6% | 6.9% | ▲ +1.4% |
| Chemicals & Petrochemicals | 0.0% | 2.6% | ▲ +2.6% |
| Personal Products | 1.1% | 1.2% | ▲ +0.1% |
| Healthcare Equipment & Supplies | 0.9% | 0.5% | ▼ -0.3% |
| Insurance | 0.5% | 0.0% | ▼ -0.5% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | Natco Pharma Limited ₹22.77 Cr |
Pharmaceuticals & Biotechnology | 1.51% |
| 2 | Navin Fluorine International Limited ₹17.79 Cr |
Chemicals & Petrochemicals | 1.18% |
| 3 | Prasol Chemicals Ltd. ₹13.28 Cr |
Chemicals & Petrochemicals | 0.88% |
| 4 | Gujarat Fluorochemicals Limited ₹8.00 Cr |
Chemicals & Petrochemicals | 0.53% |
| # | Stock | Sector | Last Weight (Aug 2026) |
|---|---|---|---|
| 1 | Global Health Limited ₹26.31 Cr |
Healthcare Services | 1.68% |
| 2 | Metropolis Healthcare Limited ₹17.32 Cr |
Healthcare Services | 1.11% |
| 3 | HDFC Life Insurance Company Limited ₹7.88 Cr |
Insurance | 0.50% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Torrent Pharmaceuticals Limited ₹56.88 Cr |
Pharmaceuticals & Biotechnology | 0.12% | 3.76% | +3.64% |
| 2 | PI Industries Limited ₹39.16 Cr |
Fertilizers & Agrochemicals | 0.95% | 2.59% | +1.64% |
| 3 | Abbott India Limited ₹89.75 Cr |
Pharmaceuticals & Biotechnology | 5.44% | 5.94% | +0.50% |
| 4 | Acutaas Chemicals Ltd ₹29.44 Cr |
Pharmaceuticals & Biotechnology | 1.48% | 1.95% | +0.47% |
| 5 | Dr. Reddy's Laboratories Limited ₹70.32 Cr |
Pharmaceuticals & Biotechnology | 4.21% | 4.65% | +0.44% |
| 6 | Anthem Biosciences Limited ₹38.89 Cr |
Pharmaceuticals & Biotechnology | 2.14% | 2.57% | +0.43% |
| 7 | Procter & Gamble Health Limited ₹41.50 Cr |
Pharmaceuticals & Biotechnology | 2.51% | 2.75% | +0.24% |
| 8 | Symbiotec Pharmalab Limited ₹13.21 Cr |
Pharmaceuticals & Biotechnology | 0.64% | 0.87% | +0.23% |
| 9 | Sai Life Sciences Limited ₹39.34 Cr |
Pharmaceuticals & Biotechnology | 2.41% | 2.60% | +0.19% |
| 10 | Gillette India Limited ₹18.57 Cr |
Personal Products | 1.09% | 1.23% | +0.14% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Mankind Pharma Limited ₹11.58 Cr |
Pharmaceuticals & Biotechnology | 2.91% | 0.77% | -2.14% |
| 2 | GlaxoSmithKline Pharmaceuticals Limited ₹11.55 Cr |
Pharmaceuticals & Biotechnology | 2.72% | 0.76% | -1.96% |
| 3 | Fortis Healthcare Limited ₹29.49 Cr |
Healthcare Services | 3.30% | 1.95% | -1.35% |
| 4 | Manipal Health Enterprises Ltd ₹8.98 Cr |
Healthcare Services | 1.24% | 0.59% | -0.65% |
| 5 | Sun Pharmaceutical Industries Limited ₹120.84 Cr |
Pharmaceuticals & Biotechnology | 8.43% | 7.99% | -0.44% |
| 6 | Pfizer Limited ₹37.85 Cr |
Pharmaceuticals & Biotechnology | 2.92% | 2.50% | -0.42% |
| 7 | Healthcare Global Enterprises Limited ₹89.52 Cr |
Healthcare Services | 6.30% | 5.92% | -0.38% |
| 8 | Molbio Diagnostics Ltd. ₹8.11 Cr |
Healthcare Equipment & Supplies | 0.87% | 0.54% | -0.33% |
| 9 | Biocon Limited ₹10.36 Cr |
Pharmaceuticals & Biotechnology | 0.99% | 0.69% | -0.30% |
| 10 | Jubilant Pharmova Limited ₹0.50 L |
Pharmaceuticals & Biotechnology | 0.25% | 0.00% | -0.25% |
42 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹120.84 Cr |
Pharmaceuticals & Biotechnology |
7.99%
|
|
| 2 |
₹89.75 Cr |
Pharmaceuticals & Biotechnology |
5.94%
|
|
| 3 |
₹89.52 Cr |
Healthcare Services |
5.92%
|
|
| 4 |
₹85.82 Cr |
Pharmaceuticals & Biotechnology |
5.68%
|
|
| 5 |
₹70.32 Cr |
Pharmaceuticals & Biotechnology |
4.65%
|
|
| 6 |
₹65.90 Cr |
Healthcare Services |
4.36%
|
|
| 7 |
₹65.07 Cr |
Healthcare Services |
4.30%
|
|
| 8 |
₹63.78 Cr |
Pharmaceuticals & Biotechnology |
4.22%
|
|
| 9 |
₹56.88 Cr |
Pharmaceuticals & Biotechnology |
3.76%
|
|
| 10 |
₹56.09 Cr |
Healthcare Services |
3.71%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.